Audacia Bioscience SCIENCE (AB) is a Windsor based biomedical
company specializing in the development of testing and the deployment
of data driven protocols for decision making to respond to Covid 19
through diagnostics.
Audacia Bioscience has developed products based on key stages of the disease and the associated care. This serves as a foundation to establish a matrix in decision making.
Testing:
•Pre infectious: Saliva test (PCR)
•Infectious: Antigen (the most important test currently) to quickly identify
infectious people.
•Post infectious: Saliva and Antibody.
•Recovered: Antibody the importance of this it to understand the prevalence of the disease.
•Research and development is currently underway for a vaccine uptake efficacy test.
Technology:
•An app for healthcare workers to enter data without paper and pen on approved devices.
•Virtual screening tool for individuals to assess their risk levels to evaluate the severity of Covid 19 if contracted.
•No contact screening tool for corporate management to identify employee
wellness and risk to make informed decisions and implement health and safety protocols.